Dermatology Update 2018 FALL

SESSIONS & ABSTRACTS

MONTREAL, FAIRMONT THE QUEEN ELIZABETH - NOVEMBER 15-18, 2018

Achieving Clarity in Rosacea

Rosacea is a chronic inflammatory skin disease characterized by transient or persistent erythema and/or inflammatory papules and pustules. Along with lifestyle modifications to avoid triggers, the goals of treatment are to control the condition by delaying or preventing progression, minimizing discomfort and alleviating symptoms, improving appearance, and sustaining remission with prolonged therapy.
This educational program will focus on the burden of rosacea and appropriate treatment options. It will also explore the definition of treatment success according to the commonly used Investigator’s Global Assessment Scale in clinical trials, and how this translates to patient-reported outcomes and time to relapse after achievement of treatment success.

LEARNING OBJECTIVES

  • Describe the burden of rosacea on a patient’s quality of life, reducing symptoms and psychological impact
  • Choose appropriate treatment options for patients with mild to severe rosacea based on Canadian clinical guidelines
  • Define treatment ‘success’ based on the Investigator’s Global Assessment (IGA) scale
  • Recognize the importance of patients achieving ‘clear’ compared to ‘almost clear’ on the IGA scale for quality of life and time to relapse after achievement of treatment success

PART OF THE EVENT

Missing Event Data
Dr. Melinda Gooderham

Dr. Melinda Gooderham

Dermatologist, Peterborough, ON

Galderma - Dermatology Update Sponsor